Research and evidence are critical for informing policies and practices in support of population healthcare and equity. In the past 2 decades, ChinaCLEN's roles and responsibilities promote evidence-based policy-making in China. Evidence-based policy has become a major part of governments' approaches for policy making and the machinery of government. In this presentation I will mainly focus on the transformation of national government healthy policy and strategies according to the expansion of evidence-based medicine in China, as well as the opportunities and challenges in the future. During the symposium following aspects in China will be discussed: 1. Organisation on the Evidence Based Health Care; 2. Impacts on Government Healthy Policy Decision-Making; 3. The prioritised research agenda special focus on clinical research identified and advocated for key research needs in 2011–2015; 4. Contributions on evidence based public health safety policy and practice; 5. Standards for scientific review of the clinical efficacy of Chinese traditional medicine; 6. Establishing integration system of traditional Chinese medicine and clinical research; 7. Improving accessibility and availability of sound evidence; and, 8. Future Opportunities and Challenges.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.